91. The Psychedelic Industry with Josh Hardman

from The Drug Science Podcast · host Drug Science

In this episode, Josh Hardman, the founder of Psychedelic Alpha, explores the multitude of challenges currently being encountered by the psychedelic industry. He engages in discussions regarding the progress of decriminalisation and legalisation initiatives, upcoming clinical trial milestones, and delves into the current state and the potential evolution of the Psychedelic industry. Psychedelic AlphaMDMAPsilocybinGHBCannabisDMTPsychoplastogensMAPSCOMPASS PathwaysNICEOregon Psilocybin Services ★ Support this podcast ★

Episode metadata supplied by the publisher feed · Published Nov 23, 2023

Embed this episode

Attribution link and audio player

Ready to play

91. The Psychedelic Industry with Josh Hardman

0:00 1:02:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Drug Science Podcast?

This episode is 1 hour and 2 minutes long.

When was this The Drug Science Podcast episode published?

This episode was published on November 23, 2023.

Can I download this The Drug Science Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!